Change of the conditions for inclusion on the list of pharmaceutical products reimbursed by National Insurance. Extension of the target population pursuant to the High Council for Public Health’s opinion of 5 July 2007 on guidelines for varicella vaccination.
-
Clinical Benefit
Substantial
The actual benefit provided by this vaccine is high in the populations recommended by the High Council of Public Health (BEH 31-32 of 24 July 2007, Session of 5 July 2007).
Listen
